Collaboration with Janssen aims to fast-track the launch and enhance accessibility to YESINTEK for patients in need.

YESINTEK, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, and ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the ...

The Humane Society of Western Montana announced they are caring for a liter of six puppies currently recovering from ...

According to the researchers, the biosensor promises to enable clinicians to diagnose mpox quickly versus waiting long ...

Fusion Antibodies plc (LON:FAB – Get Free Report) shares dropped 1.2% on Friday . The company traded as low as GBX 4.20 ($0.05) and last traded at GBX 4.25 ($0.05). Approximately 116,900 shares were ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

Galderma has reported that the randomised Phase III OLYMPIA 1 trial, which evaluated the nemolizumab monotherapy in adult ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

Fifth-generation assays: Fifth-generation assays, such as the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, use magnetic beads coated ...